ERBB3 and breast carcinoma: In the realm of cancer research, lncRNA SNHG9 acts by inhibiting the Hippo pathway through LATS1 [320], while ROR1–human epidermal growth factor receptor 3 (HER3)–lncRNA LLGL2–MAYA–NOP2/Sun RNA methyltransferase 6 is involved in regulating the Hippo–YAP pathway to control bone metastasis in breast cancer [321].